Baynas tablets 75 mg for allergic rhinitis (ramatroban)
Product Code :
Availability : 12
General information on Japanese Baynas tablets 75 mg for allergic rhinitis (ramatroban)
Package details: 100 tablets
Manufacturer: Nippon Shinyaku Co., Ltd., Japan
Active ingredient: ramatroban (chemical formula C21H21FN2O4S)
Medical effect: Baynas tablets are effective for the treatment of allergic rhinitis and its symptoms.
Contraindications and precautions: do not use for following categories of patients:
- pregnant and breastfeeding women,
- patients with bleeding tendency,
- patients with liver disorder,
- women during menstrual period.
If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.
Dosage and administration of Baynas tablets 75 mg from Japan for allergic rhinitis (ramatroban)
For adults, take 1 tablet (75 mg of the active ingredient) 2 times a day, after breakfast and dinner (or before going to bed). Do not split or chew these tablets.
How effective are Baynas tablets 75 mg from Japan for allergic rhinitis (ramatroban)?
Baynas tablets contain ramatroban, a thromboxane receptor antagonist. It works by suppressing the activities of allergic substances (thromboxane A2 and prostaglandin D2) which cause allergic rhinitis. As the result, this medicine significantly reduces such symptoms as stuffy nose, runny nose and sneezes.
Who should take Baynas tablets 75 mg from Japan?
In Japan, Baynas tablets are indicated for the treatment of the nasal obstruction in patients with allergic rhinitis. Studies proved that the treatment with ramabatron only for the period of 28 days allows to reduce all symptoms of perennial allergic rhinitis showing its high clinical efficacy (K. Ohkubo, M. Gotoh. “Effect of ramatroban, a thromboxane A2 antagonist, in the treatment of perennial allergic rhinitis”. Allergology International. Vol. 52, Issue 3, 2003, Pages 131-138). Also, in other countries Baynas tablets are used for the treatment of coronary artery disease and asthma.